Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05453006 · ClinicalTrials.gov registry record · NA

HPV Self-Sampling in Somali Women (Isbaar Project)

A NA study of Cervical Cancer and Papillomavirus Infection, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
3,367
Enrollment target
1
Study location

NCT05453006 is a NA study of Cervical Cancer and Papillomavirus Infection that has completed, run by University of Minnesota. The registered enrollment target is 3,367 participants, above the 547-participant average among 144 other Cervical Cancer trials with a reported enrollment target (516% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05453006, a NA study of Cervical Cancer and Papillomavirus Infection, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
3,367 participants
Enrollment target
1
Study location

Study Summary

This study plans to assess the effect of implementing HPV self-sampling in primary care on uptake of cervical cancer screening in 30-65 year old Somali women who are due for cervical cancer screening.

Interventions

  • DEVICE COPAN 552c.80 FLOQSwab

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 3,367 participants
Start Date 2023-02-20
Est. Completion 2025-05-19
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT05453006

The ClinicalTrials.gov registry entry for NCT05453006 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,367 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 547-participant average among 144 other Cervical Cancer trials with a reported enrollment target (516% higher). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cervical Cancer appearing as the primary indexed condition, and to 1 intervention - of which COPAN 552c.80 FLOQSwab is the first listed.

NCT05453006 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05453006 about?

NCT05453006 is a clinical study titled "HPV Self-Sampling in Somali Women (Isbaar Project)". This study plans to assess the effect of implementing HPV self-sampling in primary care on uptake of cervical cancer screening in 30-65 year old Somali women who are due for cervical cancer screening.

What is the current status of trial NCT05453006?

This trial is currently completed. It is a NA study. The enrollment target is 3,367 participants. The study started on 2023-02-20. Estimated completion is 2025-05-19.

What conditions does trial NCT05453006 study?

This clinical trial studies the following conditions: Cervical Cancer, Papillomavirus Infection, Uterine Diseases, Uterine Cervical Disease.

What interventions are being tested in trial NCT05453006?

The interventions under investigation include: COPAN 552c.80 FLOQSwab (DEVICE).

Who is sponsoring clinical trial NCT05453006?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05453006 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.